An image of pancreatic cancer – credit, PLOS ONE / DOI10.1371journal.pone.0150338 / CC 4.0. Int Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic…
Good News Network
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
Read full article at Good News Network
Disclaimer: This article summary is sourced from Good News Network. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
CNN
This little device keeps pesky mosquitoes away, and it just hit its lowest price ever
Yesterday
Defector.com
Please Tell Me Red Wine Is Good For Me
Yesterday
USA Today
After 8-year-old died of brain-eating amoeba, here's who is most at risk
Yesterday:max_bytes(150000):strip_icc()/VWH-GettyImages-174394985-6f1703b4f1a64f9cbc8b088cbd0ff953.jpg)
Verywellhealth.com